Medtronic received information via literature regarding clinical outcomes and performance of the contegra conduit as a right ventricle outflow tract implant.All data were collected from a single center between january 2002 and june 2009.The study population included 45 patients (predominantly male; mean age 4 years) all which were implanted with a medtronic contegra conduit (serial numbers not provided).Among all patients 3 deaths occurred; none of the deaths were attributed to medtronic product.Among all patients there were 9 conduit related surgical interventions (5 due to conduit stenosis and 4 due to distal stenosis).Of 8 conduit explants, all eight were found to have partially or fully calcified valve leaflets and fibrotic tissue in the supravalvular region, all eight had evidence of epithelioid giant cell immune response to foreign bodies, and three were noted with sites of ossification.No additional adverse patient effects were reported.
|